Can Polymetastatic Disease Be Arrested Using SABR? A Dosimetric Analysis to Inform Development of a Phase I Trial

Mark T. Corkum,Hatim Fakir,David A. Palma,Timothy K. Nguyen,Glenn Bauman

Can Polymetastatic Disease Be Arrested Using SABR? A Dosimetric Analysis to Inform Development of a Phase I Trial

2020

Mark T. Corkum
Hatim Fakir
David A. Palma
Timothy K. Nguyen
Glenn Bauman

e21567Background: Phase II randomized trials suggest that stereotactic ablative radiotherapy (SABR) improves progression-free and overall survival in patients with oligometastatic cancer, with phas...

Keywords:

Medicine
Medical physics
Disease
SABR volatility model

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations